Table 2.
Surgery outcomes in patients with stage IV ovarian cancer
| Primary debulking surgery N = 52 | Neo-adjuvant chemotherapy–interval debulking surgery N = 91 | p-value | |
|---|---|---|---|
| Bowel resection | 24 (46.1) | 29 (31.9) | 0.12 |
| Upper abdominal surgical proceduresa | 30 (57.7) | 37 (40.7) | 0.07 |
| Complexity of the surgery | 0.01 | ||
| Low | 15 (28.8) | 19 (20.9) | |
| Intermediate | 14 (26.9) | 48 (52.7) | |
| High | 23 (44.2) | 24 (26.4) | |
| Intraoperative complication | 6 (11.5) | 13 (14.3) | 0.83 |
| Postoperative residue | |||
| Optimal cytoreduction RD < 1 cmb | 3 (5.8) | 2 (2.2) | 0.3 |
| Complete resection: no RD | 40 (76.9) | 49 (53.8) | 0.01 |
| Postoperative complications | 25 (48.1) | 28 (30.8) | 0.06 |
Data are given as n (%)
RD residual disease, NA not applicable
a Upper abdominal surgical procedures = splenectomy, gallbladder resection, liver resection, diaphragmatic resection
b Largest residual tumor nodule measuring 1 cm or less